Literature DB >> 10228259

Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization processes.

S L Barbee1, D J Weber, M D Sobsey, W A Rutala.   

Abstract

BACKGROUND: Cryptosporidium parvum is a common cause of self-limited gastroenteritis in the normal host but may cause severe disease in immunocompromised persons. Person-to-person transmission has been well documented in households, child care centers, and hospitals. Because contaminated environmental surfaces and medical devices such as endoscopes may play a role in disease transmission, we studied the susceptibility of C parvum to chemical agents commonly used for disinfection and evaluated the efficacy of sterilization processes.
METHODS: Seven disinfectants were studied at their use dilution using a suspension test. Antimicrobial activity was assessed with the use of a cell infectivity assay.
RESULTS: All sterilization processes tested (steam, ethylene oxide, Sterrad 100) inactivated 3 logs or greater of C parvum. The only liquid disinfectant/sterilant able to inactivate greater than 3 logs of C parvum was 6% and 7.5% hydrogen peroxide. Agents that did not completely inactivate C parvum included hydrogen peroxide at lower concentrations or exposure times, peracetic acid, sodium hypochlorite, a phenolic, a quaternary ammonium compound, 2% glutaraldehyde, and ortho-phthalaldehyde.
CONCLUSIONS: Most high-level disinfectants used on endoscopes have limited efficacy against C parvum. However, the infectivity of C parvum on dry surfaces decreases rapidly. Therefore, current cleaning and high-level disinfection guidelines are adequate to prevent nosocomial transmission of C parvum by means of endoscopes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228259     DOI: 10.1016/s0016-5107(99)70389-5

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  11 in total

1.  Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings.

Authors:  Céline Coulon; Anne Collignon; Gerald McDonnell; Vincent Thomas
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

2.  Efficacy of two peroxygen-based disinfectants for inactivation of Cryptosporidium parvum oocysts.

Authors:  Joaquin Quilez; Caridad Sanchez-Acedo; Catalina Avendaño; Emilio del Cacho; Fernando Lopez-Bernad
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

3.  Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture.

Authors:  Susan C Weir; Nicholas J Pokorny; Ramon A Carreno; Jack T Trevors; Hung Lee
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

Review 4.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Authors:  Julia Kovaleva; Frans T M Peters; Henny C van der Mei; John E Degener
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Inactivation of Cryptosporidium parvum under laboratory conditions.

Authors:  Cora Delling; Ivette Holzhausen; Arwid Daugschies; Matthias Lendner
Journal:  Parasitol Res       Date:  2015-11-14       Impact factor: 2.289

6.  Silver Nanoparticles Decrease the Viability of Cryptosporidium parvum Oocysts.

Authors:  Pamela Cameron; Birgit K Gaiser; Bidha Bhandari; Paul M Bartley; Frank Katzer; Helen Bridle
Journal:  Appl Environ Microbiol       Date:  2015-10-23       Impact factor: 4.792

7.  Usefulness of Sunlight and Artificial UV Radiation Versus Chlorine for the Inactivation of Cryptosporidium Oocysts: An in Vivo Animal Study.

Authors:  Amany Soliman; Azza El-Adawy; Amany A Abd El-Aal; Marwa A Elmallawany; Reham K Nahnoush; Asmaa R Abd Eiaghni; Mohamed Sherif Negm; Amira Mohsen
Journal:  Open Access Maced J Med Sci       Date:  2018-06-10

Review 8.  Past and future trends of Cryptosporidium in vitro research.

Authors:  Alexander J Bones; Lyne Jossé; Charlotte More; Christopher N Miller; Martin Michaelis; Anastasios D Tsaousis
Journal:  Exp Parasitol       Date:  2018-12-03       Impact factor: 2.011

9.  Human challenge pilot study with Cyclospora cayetanensis.

Authors:  Edith M Alfano-Sobsey; Mark L Eberhard; John R Seed; David J Weber; Kimberly Y Won; Eva K Nace; Christine L Moe
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

10.  Giardia duodenalis: Number and Fluorescence Reduction Caused by the Advanced Oxidation Process (H2O2/UV).

Authors:  José Roberto Guimarães; Regina Maura Bueno Franco; Regiane Aparecida Guadagnini; Luciana Urbano Dos Santos
Journal:  Int Sch Res Notices       Date:  2014-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.